ANDRX (ADRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jolie Renee who wrote (57)	4/21/1998 8:55:00 PM
From: PAUL ROBERT ST. ONGE	Read Replies (2) of 127

If Andrx has filed for an ANDA for Prilosec, you can bet your bottom dollar that a NDA will follow-it! They stated in November I believe that they intend to file for a NDA version of Prilosec! Well with their generic formulation complete, you can bet that an NDA will follow, as most of the science was already done in formulating the generic. Second, NDA's typically are approved approx. in one year! The litigation if anything is different or non-existent, and the approval process is quicker. This would double or triple the revenues of the company, use a thirty times multiple (current model) and this stock will likely double or better. Hang in there, ride out this bumpy ride, then it's straight up!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next